Diagnosis and Rationale for Action against Cow’s Milk Allergy (DRACMA): A summary report - 07/08/11
Abstract |
The 2nd Milan Meeting on Adverse Reactions to Bovine Proteins was the venue for the presentation of the first consensus-based approach to the management of cow’s milk allergy. It was also the first time that the Grading of Recommendations, Assessments, Development, and Evaluation approach for formulating guidelines and recommendations was applied to the field of food allergy. In this report we present the contributions in allergen science, epidemiology, natural history, evidence-based diagnosis, and therapy synthesized in the World Allergy Organization Diagnosis and Rationale for Action against Cow’s Milk Allergy guidelines and presented during the meeting. A consensus emerged between discussants that cow’s milk allergy management should reflect not only basic research but also a newer and better appraisal of the literature in the light of the values and preferences shared by patients and their caregivers in partnership. In the field of diagnosis, atopy patch testing and microarray technology have not yet evolved for use outside the research setting. With foreseeable breakthroughs (eg, immunotherapy and molecular diagnosis) in the offing, the step ahead in leadership can only stem from a worldwide organization implementing consensus-based clinical practice guidelines to diffuse and share clinical knowledge.
Le texte complet de cet article est disponible en PDF.Key words : Cow’s milk allergy, epidemiology, amino acid formula, hydrolyzed milk formula, soy formula, hydrolyzed rice formula, skin prick test, specific IgE, oral immunotherapy, Grading of Recommendations, Assessments, Development, and Evaluation approach
Abbreviations used : AD, CMA, DRACMA, GRADE, OFC, OIT, PICO, sIgE, SPT, WAO
Plan
Disclosure of potential conflict of interest: A. Fiocchi has received support from the World Allergy Organization (WAO); he is chairman of the American College of Allergy, Asthma, and Immunology’s (ACAAI) adverse reactions to foods committee and the WAO’s food allergy special committee. H. J. Schunemann and J. Brozek have received research support from the WAO. K. Beyer has received research support from the European Union, Food Allergy and Anaphylaxis Network (FAAN), Phadia, Paul Ehrlich Institute, and the German Research Foundation. S. L. Bahna has received research support from Pharming and speaker’s honoraria from Abbott, and is president of the ACAAI. R. G. Heine is on scientific advisory boards for Nutricia Australia and Nestle Nutrition Institute Australia, and has received lecture honoraria from Nutricia Australia. H. A. Sampson has consulted for Allertein Therapeutics, LLC; has received research support from the Food Allergy Initiative (FAI) and the National Institutes of Health / National Institute of Allergy and Infectious Diseases; is a consultant/scientific advisor for FAI; and is part-owner of Herbal Springs, LLC. The remaining authors declare that they have no relevant conflicts of interest to disclose. |
Vol 126 - N° 6
P. 1119 - décembre 2010 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?